Table 2.
Report | Age at diagnosis of first twin | Sex | Morphology | Risk factors for SCD | LVOT Gradient (mmHg) | Outcomes | ICD placement |
---|---|---|---|---|---|---|---|
Wylie et al.6 | 62 | Female | Asymmetrical septal hypertrophy | None | Unknown | Asymptomatic | None |
Agirbasli et al.7 | 38 | Female | Severe asymmetrical septal hypertrophy with LVOT obstruction and SAM | None | 130 | Both responded well to beta-blockers | None |
170 | |||||||
Maron et al.8 | 18 | Male | HCM confined to posterior septum | Family history of SCD due to HCM | <30 | Asymptomatic | Unknown |
Zenovich et al.9 | 44 | Female | Mid-ventricular hypertrophy | Apical aneurysm in both twins | <30 | Asymptomatic | ICD reported in only one twin sister |
Goh et al.10 | 62 | Male | Asymmetrical septal hypertrophy | Twin brother had SCD 2 months prior | <30 | Syncope with termination of malignant ventricular tachyarrhythmia by ICD shock | ICD in one twin brother |
Maron et al.11 | 49 | Male | HCM confined to posterior inferior septum with LVOT obstruction | None | 85 | Both had paroxysmal atrial fibrillation and required septal myectomy with excellent response | None |
75 |
HCM, hypertrophic cardiomyopathy; ICD, implantable cardioverter defibrillator; LVOT, left ventricular outflow tract obstruction; SAM, systolic anterior motion of the mitral valve; SCD, sudden cardiac death.